Effect of Radioiodinated IUdR on Human Glioma Cells
Author Information
Author(s): A Neshasteh-Riz, RJ Mairs, WJ Angerson, PD Stanton, JR Reeves, R Rampling, J Owens, TE Wheldon
Primary Institution: University of Glasgow
Hypothesis
The study investigates the differential cytotoxicity of three radioiodoanalogues of IUdR to human glioma cells considering the effect of proliferative heterogeneity.
Conclusion
The study concludes that combinations of IUdR with different radioisotopes may be more effective for treating residual glioma due to the presence of non-cycling cells.
Supporting Evidence
- Monolayers treated in the exponential growth phase were most efficiently sterilized by [125I]IUdR.
- Both [125I]IUdR and [123I]IUdR were more effective than [131I]IUdR at lower concentrations.
- The survival curve for [131I]IUdR crossed the curves for the other agents at higher concentrations.
Takeaway
This study looks at how different types of radioactive medicine can kill brain cancer cells, especially when some cells are not actively growing.
Methodology
The study used clonogenic assays to compare the toxicities of three radioiodoanalogues of IUdR on human glioma cells cultured in different growth phases.
Limitations
The study does not address the effects of the treatment in vivo or the long-term outcomes of using these agents.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website